APA
Rizvi H., Sanchez-Vega F., La K., Chatila W., Jonsson P., Halpenny D., Plodkowski A., Long N., Sauter J. L., Rekhtman N., Hollmann T., Schalper K. A., Gainor J. F., Shen R., Ni A., Arbour K. C., Merghoub T., Wolchok J., Snyder A., Chaft J. E., Kris M. G., Rudin C. M., Socci N. D., Berger M. F., Taylor B. S., Zehir A., Solit D. B., Arcila M. E., Ladanyi M., Riely G. J., Schultz N. & Hellmann M. D. (20190801). Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Rizvi Hira, Sanchez-Vega Francisco, La Konnor, Chatila Walid, Jonsson Philip, Halpenny Darragh, Plodkowski Andrew, Long Niamh, Sauter Jennifer L, Rekhtman Natasha, Hollmann Travis, Schalper Kurt A, Gainor Justin F, Shen Ronglai, Ni Ai, Arbour Kathryn C, Merghoub Taha, Wolchok Jedd, Snyder Alexandra, Chaft Jamie E, Kris Mark G, Rudin Charles M, Socci Nicholas D, Berger Michael F, Taylor Barry S, Zehir Ahmet, Solit David B, Arcila Maria E, Ladanyi Marc, Riely Gregory J, Schultz Nikolaus and Hellmann Matthew D. 20190801. Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Rizvi H., Sanchez-Vega F., La K., Chatila W., Jonsson P., Halpenny D., Plodkowski A., Long N., Sauter J. L., Rekhtman N., Hollmann T., Schalper K. A., Gainor J. F., Shen R., Ni A., Arbour K. C., Merghoub T., Wolchok J., Snyder A., Chaft J. E., Kris M. G., Rudin C. M., Socci N. D., Berger M. F., Taylor B. S., Zehir A., Solit D. B., Arcila M. E., Ladanyi M., Riely G. J., Schultz N. and Hellmann M. D. (20190801). Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Rizvi Hira, Sanchez-Vega Francisco, La Konnor, Chatila Walid, Jonsson Philip, Halpenny Darragh, Plodkowski Andrew, Long Niamh, Sauter Jennifer L, Rekhtman Natasha, Hollmann Travis, Schalper Kurt A, Gainor Justin F, Shen Ronglai, Ni Ai, Arbour Kathryn C, Merghoub Taha, Wolchok Jedd, Snyder Alexandra, Chaft Jamie E, Kris Mark G, Rudin Charles M, Socci Nicholas D, Berger Michael F, Taylor Barry S, Zehir Ahmet, Solit David B, Arcila Maria E, Ladanyi Marc, Riely Gregory J, Schultz Nikolaus and Hellmann Matthew D. Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20190801.